-
Despite federal efforts, drug prices may not drop much
In January, new lower drug prices will go into effect for 10 high-cost drugs, saving Medicare members millions in out…
-
New report reveals major gaps in Medicare access, quality and affordability
A new scorecard from The Commonwealth Fund ranks states on how easily beneficiaries can access Medicare services in their area.
-
New COVID-19 vaccine guidance fuels confusion, uncertainty for older adults
ACIP’s new recommendation leaves many patients and providers unsure about current advice and whether they can obtain a COVID-19 vaccine.
-
SCOTUS will hear case threatening no-cost preventive care
If SCOTUS rules the ACA’s no-cost preventive care provision as unconstitutional, Americans would need to pay for such care or…
-
Clearing up confusion on drug price rules and revisions
It’s not yet clear what the Trump administration intends to do about current or planned efforts to lower prescription drug…
-
For Medicare members, the Inflation Reduction Act cuts drug costs, spreads out payments
In 2025, the Inflation Reduction Act will lower drug copayment costs and allow monthly payment plans for Medicare Part D…
-
For Medicare open enrollment, journalists should advise: buyer beware
For seniors seeking health insurance coverage for 2025, open enrollment comes with new risks. During open enrollment (Oct. 15 through…
-
Features of the Inflation Reduction Act you should cover now
There are at least three stories to write about other IRA provisions and how opponents of the law may file…
-
Go beyond the headlines to cover stories on drug-price negotiations
Consider these story angles when reporting on the Biden administration’s recent agreement with drug manufacturers to lower prices.
-
How to cover the sharp rise in spending for diabetes and weight loss drugs
Consumer demand for expensive diabetes and weight loss medications like Ozempic could drive up insurance premiums and Medicare costs.